CBAY - Cymabay Therapeu - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Cymabay Therapeu's activity chart (see below) currently has 172 price targets and 137 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.23% with an average time for these price targets to be met of 755.13 days.

Most recent stock forecast was given by from WESTPARK on 29-Feb-2024.

Best performing analysts who are covering CBAY - Cymabay Therapeu:

Eliana Merle Pasha Sarraf David Bouchey Yasmeen Rahimi

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Feb-2024

$32.5

$0.02 (0.06%)

2 years 7 months 24 days ago
(29-Feb-2024)

15/16 (93.75%)

$0.31 (0.96%)

489

Buy Since 12-May-2020

$32.5

$0.02 (0.06%)

$12

2 years 8 months 3 days ago
(20-Feb-2024)

3/4 (75%)

$0.3 (0.93%)

384

Buy Since 12-May-2020

$32.5

$0.02 (0.06%)

$25

2 years 8 months 9 days ago
(14-Feb-2024)

8/9 (88.89%)

$0.32 (0.99%)

1093

Buy Since 03-Aug-2020

$32.5

2 years 8 months 9 days ago
(14-Feb-2024)

12/14 (85.71%)

$0.38 (1.18%)

959

Buy Since 05-Jul-2023

$26

2 years 8 months 10 days ago
(13-Feb-2024)

4/4 (100%)

$3.37 (14.89%)

107

Show more analysts

Please expand the browser size to see the chart

What is CBAY (Cymabay Therapeu) average time for price targets to be met?

On average it took 755 days for the stock forecasts to be reached, with an average price target met ratio of 89.23%.

Which analyst most recently updated their price target on CBAY (Cymabay Therapeu)?

Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?

has 0 price targets and 0 ratings on CBAY

Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?

Eliana Merle with the highest potential upside of $0.02

Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?

Sa'ar Yaniv with the lowest potential downside of -$26.48
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?